Consumer News Coronavirus Update Pfizer S Vaccine 95 Percent Effective Production Issues Could Inhibit Vaccine Distribution
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Consumer News Coronavirus Update Pfizer S Vaccine 95 Percent Effective Production Issues Could Inhibit Vaccine Distribution is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Final analysis: Pfizer's COVID-19 vaccine 95% effective, company to seek authorization within 'days'

A final analysis of a COVID-19 vaccine candidate produced by Pfizer and BioNTech shows that the drug is 95% effective in preventing the coronavirus, and the companies say they hope to apply for ... Read More
US negotiating with Pfizer for millions more doses of COVID-19 vaccine

WASHINGTON - The U.S. government is negotiating with Pfizer to acquire tens of millions of additional vaccine doses in exchange for helping the pharmaceutical giant gain better access to manufacturing ... Read More
FDA Approves Pfizer's Coronavirus Vaccine for Emergency Use

WASHINGTON (AP/CBS13) -- The U.S. has given the final go-ahead to the nation's first COVID-19 vaccine, launching emergency vaccinations in a bid to end the pandemic. After Friday's decision by the ... Read More
90-year-old woman in England is the first to receive initial dose of Pfizer's COVID-19 vaccine

90-year-old Margaret Keenan of the United Kingdom became the first person to receive an initial dose of Pfizer's COVID-19 vaccine on Tuesday — a major landmark and something that officials are calling ... Read More
CDC advisers to review data on Pfizer-BioNTech COVID-19 vaccine

(Reuters) - A U.S. Centers for Disease Control and Prevention (CDC) advisory panel will meet on Friday to review data on the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE, with a vote ... Read More
Pfizer says its vaccine is safe and effective in kids age 12-15

Pfizer announced Wednesday that its COVID-19 vaccine is safe and strongly protective in kids as young as 12, a step toward possibly beginning shots in this age group before they head back to school in ... Read More
CDC director signs off on Pfizer's COVID-19 vaccine for children ages 5-11

Children as young as 5 can now receive the Pfizer COVID-19 vaccine. Centers for Disease Control Director Dr. Rochelle Walensky signed off on a recommendation for an emergency use authorization for ... Read More
FDA issues emergency approval Pfizer's COVID-19 vaccine for kids as young as 5

WASHINGTON — The FDA on Friday issued emergency approval for a smaller dose version of Pfizer's COVID-19 vaccine for use in children aged 5 to 11. The agency's decision comes just days after the ... Read More
FDA approves updated COVID-19 shots but limits access for some kids and adults

U.S. regulators approved updated COVID-19 shots Wednesday but limited their use for many Americans - and removed one of the two vaccines available for young children. The new shots from Pfizer, ... Read More
With scant power or freezers, Pfizer vaccine brings little cheer to coronavirus-hit India

NEW DELHI, Nov 11 (Thomson Reuters Foundation) - Despite hopes raised by Pfizer's COVID-19 vaccine, it will take huge efforts for India to defeat the coronavirus, with its 1.3 billion population and ... Read More
Blow Us A Whistle

Comments (Whistles) Designed By Disqus

